The role of team science in the future of male contraception†.

contraception human reproduction male sexual function reproductive behavior

Journal

Biology of reproduction
ISSN: 1529-7268
Titre abrégé: Biol Reprod
Pays: United States
ID NLM: 0207224

Informations de publication

Date de publication:
04 08 2020
Historique:
received: 15 02 2020
revised: 19 05 2020
accepted: 21 05 2020
pubmed: 30 5 2020
medline: 25 9 2021
entrez: 30 5 2020
Statut: ppublish

Résumé

Efforts to develop a male contraceptive method beyond condoms and vasectomy have been on-going for nearly 70 years. During this time, there have been ebbs and modest flows of resources available to support product development, but not at a level sufficient to carry research efforts through to market. The small community of researchers that have continued to pursue the development of male contraceptives is comprised of dedicated scientists who have a great deal of knowledge and experience to offer. While collaboration has been an organic outcome of limited resources, competing research objectives and geographically diverse locations have made consistent and sustained progress challenging, particularly for those working in the earliest stages of developing nonhormonal, reversible male contraceptive methods. While the past decade has seen an increase in funding to the field, the levels are still modest when placed in the context of actual costs to bring products to market. In addition, there are challenges still to be identified given that there is no regulatory precedent for these products. These challenges present an excellent use case for the application of design-thinking or human centered design, as a means of generating novel solutions. By engaging those with deep technical expertise in the field of male contraception as well as thought leaders from other fields of practice, design-thinking offers an opportunity to identify potential strategies, including nontraditional approaches, capable of driving the product development process forward, in a faster and more efficient manner.

Identifiants

pubmed: 32467962
pii: 5848265
doi: 10.1093/biolre/ioaa086
pmc: PMC7401372
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

167-175

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of Society for the Study of Reproduction.

Références

Hum Reprod. 2000 Mar;15(3):637-45
pubmed: 10686211
PLoS One. 2017 Nov 1;12(11):e0186744
pubmed: 29091935
N Engl J Med. 2019 Aug 1;381(5):397-399
pubmed: 31365795
Hum Reprod. 2000 Mar;15(3):646-9
pubmed: 10686212
Motiv Sci. 2018 Dec;4(4):347-361
pubmed: 30534581
Womens Health Issues. 2020 Jan - Feb;30(1):3-6
pubmed: 31735580
Am Psychol. 2018 May-Jun;73(4):532-548
pubmed: 29792466

Auteurs

Heather L Vahdat (HL)

Male Contraceptive Initiative, Durham, North Carolina.

Kevin Shane (K)

Male Contraceptive Initiative, Durham, North Carolina.

Logan M Nickels (LM)

Male Contraceptive Initiative, Durham, North Carolina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH